Bioextrax Balance Sheet Health
Financial Health criteria checks 6/6
Bioextrax has a total shareholder equity of SEK19.8M and total debt of SEK0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are SEK21.4M and SEK1.7M respectively.
Key information
0%
Debt to equity ratio
SEK 0
Debt
| Interest coverage ratio | n/a |
| Cash | SEK 12.10m |
| Equity | SEK 19.79m |
| Total liabilities | SEK 1.66m |
| Total assets | SEK 21.45m |
Recent financial health updates
Is Bioextrax (STO:BIOEX) In A Good Position To Invest In Growth?
Apr 22
Companies Like Bioextrax (NGM:BIOEX) Are In A Position To Invest In Growth
Mar 07Is Bioextrax (NGM:BIOEX) In A Good Position To Deliver On Growth Plans?
Mar 03Is Bioextrax (NGM:BIOEX) In A Good Position To Invest In Growth?
Nov 19Recent updates
Financial Position Analysis
Short Term Liabilities: BIOEX's short term assets (SEK14.3M) exceed its short term liabilities (SEK1.7M).
Long Term Liabilities: BIOEX has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: BIOEX is debt free.
Reducing Debt: BIOEX has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: BIOEX has sufficient cash runway for 7 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: BIOEX is forecast to have sufficient cash runway for 5 months based on free cash flow estimates, but has since raised additional capital.